[go: up one dir, main page]

NO20022007L - Krystaller av et oksyiminoalkansyrederivat og deres anvendelse som antidiabetika - Google Patents

Krystaller av et oksyiminoalkansyrederivat og deres anvendelse som antidiabetika

Info

Publication number
NO20022007L
NO20022007L NO20022007A NO20022007A NO20022007L NO 20022007 L NO20022007 L NO 20022007L NO 20022007 A NO20022007 A NO 20022007A NO 20022007 A NO20022007 A NO 20022007A NO 20022007 L NO20022007 L NO 20022007L
Authority
NO
Norway
Prior art keywords
crystals
acid derivative
antidiabetic agents
oxyiminoalkanoic acid
oxyiminoalkanoic
Prior art date
Application number
NO20022007A
Other languages
English (en)
Other versions
NO20022007D0 (no
Inventor
Yu Momose
Hiroshi Imoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20022007D0 publication Critical patent/NO20022007D0/no
Publication of NO20022007L publication Critical patent/NO20022007L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20022007A 1999-10-29 2002-04-26 Krystaller av et oksyiminoalkansyrederivat og deres anvendelse som antidiabetika NO20022007L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30834699 1999-10-29
PCT/JP2000/007482 WO2001032637A1 (en) 1999-10-29 2000-10-26 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics

Publications (2)

Publication Number Publication Date
NO20022007D0 NO20022007D0 (no) 2002-04-26
NO20022007L true NO20022007L (no) 2002-06-24

Family

ID=17979966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022007A NO20022007L (no) 1999-10-29 2002-04-26 Krystaller av et oksyiminoalkansyrederivat og deres anvendelse som antidiabetika

Country Status (18)

Country Link
US (1) US6777435B1 (no)
EP (1) EP1224178B1 (no)
KR (1) KR100433885B1 (no)
CN (1) CN1407975A (no)
AR (1) AR031078A1 (no)
AT (1) ATE243684T1 (no)
AU (1) AU7958100A (no)
CA (1) CA2388200A1 (no)
CL (1) CL2000002938A1 (no)
CO (1) CO5261530A1 (no)
DE (1) DE60003577T2 (no)
HU (1) HUP0203884A3 (no)
MY (1) MY135840A (no)
NO (1) NO20022007L (no)
PE (1) PE20010761A1 (no)
PL (1) PL364171A1 (no)
TW (1) TW558554B (no)
WO (1) WO2001032637A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072695A1 (en) * 2000-03-28 2001-10-04 Takeda Chemical Industries, Ltd. Neovascularization inhibitors
WO2002080935A1 (en) * 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
DE60231295D1 (de) 2001-04-04 2009-04-09 Ortho Mcneil Janssen Pharm R und ppar modulatoren
JP4399251B2 (ja) 2001-05-30 2010-01-13 キッセイ薬品工業株式会社 グルコピラノシルオキシピラゾール誘導体、それを含有する医薬組成物、その医薬用途およびその製造中間体
TWI327462B (en) * 2002-01-18 2010-07-21 Sumitomo Chemical Co Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
US7556926B2 (en) 2002-05-24 2009-07-07 Takeda Pharmaceuticals Company Ltd. Methods for screening insulin-sensitizing agents
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
WO2006036686A2 (en) * 2004-09-24 2006-04-06 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
EP1937297A2 (en) * 2005-09-08 2008-07-02 Gastrotech Pharma A/S Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort
TW201138843A (en) 2009-12-18 2011-11-16 Colgate Palmolive Co Biguanide preservation of precipitated calcium carbonate
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects
EP3094380B1 (en) 2014-01-17 2021-04-28 Cornell University Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
KR102281228B1 (ko) 2019-09-03 2021-07-22 신창수 과수나무의 가지지지용 파이프클램프

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR029876A1 (es) * 1998-05-11 2003-07-23 Takeda Pharmaceutical Compuesto de acido oxiiminoalcanoilo, composicion farmaceutica y agente para controlar receptores relacionados con retinoide que lo comprenden y su uso
EP1227081A4 (en) * 1999-10-29 2004-08-11 Takeda Chemical Industries Ltd PROCESS FOR THE PREPARATION OF OXYMINOALKANOIC ACID DERIVATIVES

Also Published As

Publication number Publication date
EP1224178B1 (en) 2003-06-25
CO5261530A1 (es) 2003-03-31
AU7958100A (en) 2001-05-14
WO2001032637A1 (en) 2001-05-10
PE20010761A1 (es) 2001-08-01
CL2000002938A1 (es) 2009-05-15
CA2388200A1 (en) 2001-05-21
MY135840A (en) 2008-07-31
EP1224178A1 (en) 2002-07-24
KR100433885B1 (ko) 2004-06-04
AR031078A1 (es) 2003-09-10
NO20022007D0 (no) 2002-04-26
PL364171A1 (en) 2004-12-13
ATE243684T1 (de) 2003-07-15
TW558554B (en) 2003-10-21
HK1044536A1 (en) 2002-10-25
DE60003577D1 (de) 2003-07-31
DE60003577T2 (de) 2004-04-29
KR20010102429A (ko) 2001-11-15
CN1407975A (zh) 2003-04-02
HUP0203884A3 (en) 2005-01-28
HUP0203884A2 (hu) 2003-03-28
US6777435B1 (en) 2004-08-17

Similar Documents

Publication Publication Date Title
NO20014409D0 (no) Dimere forbindelser og deres anvendelse som inhibitorer av neuraminidase
NO20020383D0 (no) Mutilinderivater og deres anvendelse som anti-bakterielle midler
DK1475377T3 (da) Indol-derivater og deres anvendelse som inhibitorer for phosphodiesterase 4
NO20021253L (no) Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
DK1216247T3 (da) Imidazoimidazoler og triazoler som anti-inflammatoriske midler
NO20012688D0 (no) Benzamidderivater og anvendelse derav som APOB-100 sekresjonsinhibitorer
NO996491L (no) 4-brom- eller 4-iod-fenylaminobenzhydroksamsyre-derivater og deres anvendelse som MEK-inhibitorer
FI20000677A7 (fi) Oksiimijohdannaiset ja niiden käyttö latentteina happoina
DK1133477T3 (da) Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
NO20024402D0 (no) Cykliske <beta>-aminosyrederivater som inhibitorer av matriksmetalloproteaser og TNF-<alfa>
DK1204649T3 (da) Arylmethylcarbonylaminothiazolderivater og deres anvendelse som antitumormidler
NO20005265D0 (no) Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser
NO20030298D0 (no) Nye heteroarylderivater og deres anvendelse som farmasöytiske midler
NO20022007D0 (no) Krystaller av et oksyiminoalkansyrederivater og deres anvendelse som antidiabetika
NO20010479L (no) Tricykliske sulfonamider og deres derivater som inhibitorer av matriksmetalloproteinaser
NO20015897D0 (no) Indolylpiperidinderivater som antihistaminiske og antiallergiske midler
DK1150996T3 (da) Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer
EE03745B1 (et) Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena
NO951147D0 (no) Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
DK1173436T3 (da) Thiazolidindionderivat og anvendelse deraf som antidiabetikum
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
NO20013669L (no) Reverse hydroksamatinhibitorer av matriks metalloproteinaser
DK1187812T3 (da) Substituerede phenylcyclohexancarboxylsyreamider og deres anvendelse som adenosinoptagelses-inhibitorer
DK1200409T3 (da) Substituerede isoquinolinderivater og deres anvendelse som krampestillende midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application